Advertisement

Clinical Rheumatology

, Volume 29, Issue 11, pp 1211–1216 | Cite as

Etiopathogenesis of Behçet's disease with emphasison the role of immunological aberrations

  • Violetta D. KapsimaliEmail author
  • Meletios A. Kanakis
  • George A. Vaiopoulos
  • Phaedon G. Kaklamanis
Review Article

Abstract

Behçet's disease (BD) is a chronic multisystemic inflammatory disorder of unknown origin consisting of oral aphthous ulcers, ocular symptoms, skin lesions, and genital ulcerations. It has many features in common with systemic vasculitides and is more prevalent in countries along the ancient Silk route. Immune-mediated mechanisms play a major role in the pathogenesis of the disease, and inflammatory mediators are also involved. BD is not considered to be an autoimmune disorder, and the character of the disease needs to be clarified. Immunological aberrations in BD have been extensively studied by many investigators; genetic factors have been related to disease susceptibility, but their exact role in the development of disease is uncertain. Environmental factors such as infectious agents have also been implicated in the etiology of BD. However, the etiopathogenesis of the disease remains to be elucidated. Factors involved in the immunopathogenesis of BD with emphasis on the role of immunological aberrations are analyzed in this review.

Keywords

Behçet's disease Genetic Immunologic Inflammatory mediators Pathophysiology Thrombophilic factors 

Notes

Disclosures

None.

References

  1. 1.
    Kaklamani VG, Vaiopoulos G, Kaklamanis P (1998) Behçet's disease. Semin Arthritis Rheum 27:197–217CrossRefPubMedGoogle Scholar
  2. 2.
    Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the United States: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMedGoogle Scholar
  3. 3.
    Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kylac M et al (2003) Prevalence of Behçet's disease in Instanbul, Turkey. Int J Dermatol 42:803–806CrossRefPubMedGoogle Scholar
  4. 4.
    Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 192:149–155CrossRefPubMedGoogle Scholar
  5. 5.
    Gul A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19(Suppl 24):S6–S12PubMedGoogle Scholar
  6. 6.
    Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E et al (2007) Interrelated modulation of endothelial function in Behçet's disease by clinical activity and corticosteroid treatment. Arthritis Res Ther 9:R90CrossRefPubMedGoogle Scholar
  7. 7.
    Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545CrossRefPubMedGoogle Scholar
  8. 8.
    Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(suppl 38):S1–S2PubMedGoogle Scholar
  9. 9.
    Aksu K, Kabasakal Y, Sayiner A, Keser G, Oksel F, Bilgic A et al (1999) Prevalence of hepatitis A, B, C and E viruses in Behçet's disease. Rheumatology 38:1279–1281CrossRefPubMedGoogle Scholar
  10. 10.
    Lehner T (1997) The role of heat shock protein, microbial and autiimmune agents in the aetiology of Behçet's disease. Int Rev Immun 14:21–32Google Scholar
  11. 11.
    Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R et al (2007) Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clin Exp Dermatol 32:186–190CrossRefPubMedGoogle Scholar
  12. 12.
    Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S (2007) H. pylori infections in patients with Behçet's disease. World J Gastroenterol 13:2983–2985PubMedGoogle Scholar
  13. 13.
    Ayaslioglu E, Duzgun N, Erkek E, Inal A (2004) Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease. Scand J Infect Dis 36:428–430CrossRefPubMedGoogle Scholar
  14. 14.
    Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMedGoogle Scholar
  15. 15.
    Isogai E, Hirata M, Isogai H, Matuo K, Kimura K, Yokota K et al (2003) Antimicrobial activity of synthetic human CAP 18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease. Adv Exp Med Biol 528:195–200CrossRefPubMedGoogle Scholar
  16. 16.
    Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H et al (1994) Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram positive bacterium Streptococcus sanguis. Eur J Immunol 24:1536–1543CrossRefPubMedGoogle Scholar
  17. 17.
    Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H et al (2009) The close association between dental and periodontal treatments and oral ulcers course in Behçet's disease: a perspective clinical study. J Oral Pathol Med 38:410–415CrossRefPubMedGoogle Scholar
  18. 18.
    Krause I, Monselise Y, Milo G, Weinberger A (2002) Anti-Saccharomyces cerevisiae antibodies—a novel serologic marker of Behçet's disease. Clin Exp Rheumatol 20(suppl26):S-21–S-24Google Scholar
  19. 19.
    Filik L, Biyikoglu I (2008) Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol 14:7271CrossRefPubMedGoogle Scholar
  20. 20.
    Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L et al (2001) HSP60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 45:904–909CrossRefPubMedGoogle Scholar
  21. 21.
    Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, Vaughan R, Lehner T (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151:2273–2282PubMedGoogle Scholar
  22. 22.
    Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 21:S44–S48PubMedGoogle Scholar
  23. 23.
    Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H (2008) Serum levels of free heat shock protein 70 and anti-HSP70 and elevated in Behçet's disease. Clin Exp Rheumatol 26(suppl 50):S96–S98PubMedGoogle Scholar
  24. 24.
    Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Sano CD, Licata G (2003) Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease-evidence for expansion and tumor necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther 5:R262–R268CrossRefPubMedGoogle Scholar
  25. 25.
    Bank I, Duvdevani M, Livneh A (2003) Expansion of gammadelta T cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 141:33–40CrossRefPubMedGoogle Scholar
  26. 26.
    Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M (1994) Phenotype and functional profile of T cells expressing gammadelta receptor patients with active Behçet's disease. J Rheumatol 21:2301–2306PubMedGoogle Scholar
  27. 27.
    Yasuoka H, Yamaguchi Y, Mizuki N, Nishida T, Kawakami Y, Kuwana M (2008) Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol 26(suppl 50):S59–S63PubMedGoogle Scholar
  28. 28.
    Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 19(Suppl 24):S19–S24PubMedGoogle Scholar
  29. 29.
    Pay S, Simşek I, Erdem H, Dinç A (2007) Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27:417–424CrossRefPubMedGoogle Scholar
  30. 30.
    Carletto A, Pacor ML, Biasi D, Caramaschi P, Zeminian S, Bellavite P, Bambara LM (1997) Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 24:1332–1336PubMedGoogle Scholar
  31. 31.
    Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE (2000) Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284CrossRefPubMedGoogle Scholar
  32. 32.
    Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39CrossRefPubMedGoogle Scholar
  33. 33.
    Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease. Arthritis Rheum 42:1967–1974CrossRefPubMedGoogle Scholar
  34. 34.
    Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 50(7):2291–2295CrossRefPubMedGoogle Scholar
  35. 35.
    Protogerou A, Lekakis J, Stamatelopoulos K, Aznaouridis K, Karatzis E, Ikonomidis I et al (2003) Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 528:399–404CrossRefPubMedGoogle Scholar
  36. 36.
    Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Metin A et al (2004) Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Am J Cardiol 94:522–525CrossRefPubMedGoogle Scholar
  37. 37.
    Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behçet's disease and thrombophilia. Ann Rheum Dis 60:1081–1085CrossRefPubMedGoogle Scholar
  38. 38.
    Fadini GP, Tognon S, Rodriguez L, Boscaro E, Baesso I, Avogaro A et al (2009) Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease. Clin Exp Rheumatol 27:814–821PubMedGoogle Scholar
  39. 39.
    Espinosa G, Font J, Tassies D, Viddaler A, Deulofeu R, Lopez-Soto A (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation and thrombomodulin. Am J Med 112:37–43CrossRefPubMedGoogle Scholar
  40. 40.
    Menashi S, Tribout B, Dosquet C, Le Toumelin P, Piette JC, Wechsler B et al (2008) Strong association between plasma thrombomodulin and pathergy test in Behçet's disease. Ann Rheumatol Dis 67:892–893CrossRefGoogle Scholar
  41. 41.
    Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessement of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Clin Chem Lab Med 45:73–77CrossRefPubMedGoogle Scholar
  42. 42.
    Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro SS (2003) Antiendothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol 21(suppl 30):S27–S30PubMedGoogle Scholar
  43. 43.
    Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 46:2025–2035CrossRefGoogle Scholar
  44. 44.
    Kalayciyan A, Zouboulis C (2007) An update on Behçet's disease. J Eur Acad Dermatol Venereol 21:1–10CrossRefPubMedGoogle Scholar
  45. 45.
    Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K et al (2005) Lipid profile and anticardiolipin antibodies in Behçet's disease. Arch Med Res 36:387–392CrossRefPubMedGoogle Scholar
  46. 46.
    Kandolf-Sekulovic L, Pavlovic MD, Glisic B, Petronijevic M, Ristic G, Mijuskovic Z et al (2005) Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases. J Eur Acad Dermatol Venereol 19:484–488CrossRefPubMedGoogle Scholar
  47. 47.
    Al Mutawa SA, Hegab SM (2004) Behçet's disease. Clin Exp Med 4:103–131CrossRefPubMedGoogle Scholar
  48. 48.
    Mor F, Weinberger A, Cohen IR (2002) Identification of alpha tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol 32:356–365CrossRefPubMedGoogle Scholar
  49. 49.
    Lu Y, Ye P, Chen SL, Ten EM, Chen EK (2005) Identification of kinektin as a novel Behçet's disease autoantigen. Arthritis Res Ther 7:R1133–R1139CrossRefPubMedGoogle Scholar
  50. 50.
    Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P (1988) HLA antigens and Adamantiades-Behçet's disease (ABD) in Greeks. Clin Exp Rheumatol 6:277–280PubMedGoogle Scholar
  51. 51.
    Kaya TI, Dur H, Tursen U, Gurler A (2002) Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease. Clin Exp Dermatol 27:498–501CrossRefPubMedGoogle Scholar
  52. 52.
    Mizuki N, Yabuki K, Ota M, Katsuyama Y, Ando H, Nomura E et al (2002) Microsatellite polymorhism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 60:396–399CrossRefPubMedGoogle Scholar
  53. 53.
    Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al (2010) Genetics of Behçet's disease inside and outside the MHC. Ann Rheum Dis 69:747–754Google Scholar
  54. 54.
    Durrani K, Papaliodis GN (2008) The genetics of Adamantiades Behçet's disease. Semin Ophthalmol 23:73–79CrossRefPubMedGoogle Scholar
  55. 55.
    Direskeneli H (2001) Behçet's disease: infectious aetiology, new autoantigens and HLA-B51. Ann Rheum Dis 60:996–1002CrossRefPubMedGoogle Scholar
  56. 56.
    Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K et al (2003) Mapping of the HLA association in Behçet's disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813CrossRefPubMedGoogle Scholar
  57. 57.
    Mizuki N, Meguro A, Tohnai I, Gul A, Ohno S, Mizuki N (2007) Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Ophthalmol 51:431–436CrossRefPubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2010

Authors and Affiliations

  • Violetta D. Kapsimali
    • 1
    Email author
  • Meletios A. Kanakis
    • 2
  • George A. Vaiopoulos
    • 2
  • Phaedon G. Kaklamanis
    • 3
  1. 1.Department of Microbiology, Medical SchoolUniversity of AthensAthensGreece
  2. 2.First Department of Internal MedicineUniversity of Athens, Laikon HospitalAthensGreece
  3. 3.Athens Medical CenterAthensGreece

Personalised recommendations